Smith+Nephew Introduces Coriograph Pre-Op Planning for Hip Replacements
FDA-Cleared Innovation for Personalized Surgery Smith+Nephew (NYSE: SNN) has received FDA clearance for Coriograph, its pre-operative planning and modeling service, specifically for total hip arthroplasty